In this study, through network pharmacology analysis, it was found that the treatment of kidney stones by CA mainly involved the response to oxidative stress, the inflammatory response and the NF-κB and MAPK signaling pathway. This evidence concerns the gene NFKB1 and nephrolithiasis.